Mercer Global Advisors Inc Agenus Inc Transaction History

Mercer Global Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.12 - $1.88 $560 - $940	-500 Reduced 0.36%	139,633 $158,000
Q2 2023 Aug 14, 2023	BUY	$1.31 - $2.04 $183,574 - $285,871	140,133 New	140,133 $224,000
Q2 2021 Aug 10, 2021	SELL	$2.56 - $5.49 $115,200 - $247,050	-45,000 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$2.69 - $5.25 $121,050 - $236,250	45,000 New	45,000 $122,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.